# Advisor Review - Gemini-3-Flash

**Role:** Academic advisor checking for fatal errors
**Model:** gemini-3-flash-preview (ai_studio)
**Paper:** paper.pdf
**Timestamp:** 2026-02-17T15:38:56.574593
**Route:** Direct Google API + PDF
**Tokens:** 17278 in / 695 out
**Response SHA256:** 7554661cbef47785

---

I have reviewed the draft paper for fatal errors that would preclude submission to a journal.

**FATAL ERROR 1: Data-Design Alignment**
- **Location:** Section 1 (Abstract), Section 4.4 (Census ACS Population Data), and Table 3.
- **Error:** The paper claims to use data through 2024 to estimate effects, but Section 4.4 explicitly states: "Population data is available for 2018–2023; I extrapolate 2024 values from 2023." While extrapolation is a common fix, two of the primary outcomes in Table 3—"Providers/100k" and "Spending/Capita"—depend entirely on these denominators. Using extrapolated population data for the final year of a 7-year panel to calculate the primary dependent variable for 2024 is a design misalignment when claiming 2024 coverage.
- **Fix:** Either restrict the analysis to 2018–2023 or clearly label the 2024 per-capita results as based on projected denominators in the tables and abstract.

**FATAL ERROR 2: Internal Consistency**
- **Location:** Table 3 vs. Section 6.1 (Page 12)
- **Error:** The text in Section 6.1 states: "Column (1) reports the Callaway-Sant’Anna ATT on log HCBS providers: -0.161 (SE = 0.088, p = 0.069)." However, Table 3 Column (1) reports the ATT as "-0.1605*". While these are mathematically the same via rounding, the p-value cited in text (0.069) is inconsistent with the p-value cited in the Abstract (p = 0.069) versus Table 5, which lists the same "Main" result but with different significance stars in other contexts.
- **Fix:** Ensure the coefficient and p-value rounding is identical in the Abstract, Table 3, and the Results text.

**FATAL ERROR 3: Internal Consistency (Cohort Definitions)**
- **Location:** Table 2 vs. Table 4 vs. Appendix B.1
- **Error:** In Table 2, the note states there are 30 treated states, of which 21 were treated in 2018 and 9 were treated between 2019-2023. This matches Table 4 and Appendix B.1. However, Figure 3 (the map) shows states colored for "2024" treatment (e.g., Nebraska is colored for 2023, but the legend includes a 2024 color). If the data ends in Dec 2024, a state first treated in 2024 (like Hawaii or others often associated with 2024 hikes) would have no "post" periods in an annual model.
- **Fix:** Clarify if any states are considered "2024 cohorts" and how they are handled, as they currently appear in the map legend but are excluded from the N in Table 4.

**ADVISOR VERDICT: FAIL**